Bio-Rad Laboratories | BIO - الأصول





الأصول تغيير تاريخ
Abbott USD 108.25B 968M 2026-09
Agilent USD 13.97B 902M 2026-06
Becton, Dickinson and Co. USD 50.79B 60M 2026-09
Bio Techne USD 2.64B 50.09M 2026-09
Bio-Rad Laboratories USD 10.78B 531.1M 2026-09
Bruker USD 5.83B 224.6M 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Danaher USD 93.28B 914M 2026-09
General Electric Aerospace USD 127.2B 477M 2026-09
Illumina USD 6.81B 162M 2026-09
IQVIA Holdings USD 30.47B 593M 2026-09
Laboratory Of America USD 18.92B 392.3M 2026-09
Merck USD 132.77B 2.97B 2026-09
Mettler Toledo International USD 3.7B 24.53M 2026-09
Myriad Genetics USD 638.9M 34.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Pacific Biosciences Of California USD 721.1M 30.75M 2026-09
Quest Diagnostics USD 17.22B 282M 2026-09
Repligen USD 2.93B 23.77M 2026-09
Revvity USD 11.49B 555.49M 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Siemens EUR 169.87B 2.32B 2026-09
Standard Biotools USD 635.33M 8.11M 2026-09
Thermo Fisher Scientific USD 114.23B 1.06B 2026-09
Tosoh JPY 1.5T 28.86B 2026-09
Waters USD 24.12B 636M 2026-09